Atovaquone Oral Suspension USP, 750 mg/5 mL recall — FDA D-0567-2023
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Overview of recall records associated with Camber Pharmaceuticals, Inc., including dates, categories and classifications where available.
Classification mix: Class III: 1, Class I: 1.
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
This page summarizes recall records in which the official source identifies Camber Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.